Brevan Howard Capital Management LP Jazz Pharmaceuticals PLC Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 4,106 shares of JAZZ stock, worth $425,094. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,106
Previous 12,556
67.3%
Holding current value
$425,094
Previous $1.54 Million
68.01%
% of portfolio
0.0%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
513Shares Held
57MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$732 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$668 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$255 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$246 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$155 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.49B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...